ICD-10-CM Billable Code

M00.19

Pneumococcal polyarthritis

Clinical Classification Guidelines

Medical Intelligence & Overview

Pneumococcal polyarthritis is a type of joint infection caused by the bacteria Streptococcus pneumoniae, commonly known as pneumococcus. This condition involves inflammation of multiple joints simultaneously, leading to pain, swelling, and stiffness. It primarily affects individuals with weakened immune systems or pre-existing health issues but can occur in otherwise healthy people as well. Recognizing its symptoms and understanding the underlying causes are crucial for effective management and treatment.

Causes & Symptoms

Clinical Causes: Infection with Streptococcus pneumoniae bacteria, which can spread through respiratory droplets or direct contact Spread of bacteria via the bloodstream (bacteremia) to various joints, resulting in infection Pre-existing health conditions that impair immune function, such as HIV/AIDS or diabetes Recent respiratory infections, which may increase the risk of bacterial spread to joints Invasive pneumococcal disease, such as pneumonia or meningitis, which can incorporate bacteria into the bloodstream Trauma or injuries that provide a portal of entry for bacteria into the joint tissue

Key Symptoms: Multiple joint pain, typically affecting large joints such as knees, hips, or shoulders Swelling and redness around affected joints Stiffness particularly noticeable after periods of rest Fever and chills, indicating systemic infection Fatigue and general feelings of malaise Limited joint mobility due to swelling and pain Potential for joint destruction if untreated

Diagnostic & Treatment

Diagnosis Path: Diagnosing pneumococcal polyarthritis involves several steps, including clinical evaluation and laboratory tests. Blood tests may reveal elevated inflammatory markers, such as ESR or CRP, indicating infection. Joint fluid analysis obtained through aspiration can identify bacteria directly and help distinguish bacterial from other causes of arthritis. Cultures of joint fluid or blood are crucial to confirm Streptococcus pneumoniae as the infectious agent. Imaging studies like X-rays may show joint inflammation or damage but are not definitive for infection. Early diagnosis is critical to initiate appropriate treatment promptly.

Treatment Protocols: Treatment for pneumococcal polyarthritis typically includes antibiotics targeted against Streptococcus pneumoniae. The choice of antibiotic depends on local resistance patterns and susceptibility testing. Often, intravenous antibiotics are administered initially, followed by oral antibiotics to complete therapy. Supportive care may involve pain management and anti-inflammatory medications. Resting affected joints and immobilization can help reduce pain and prevent further damage. In some cases, surgical intervention might be necessary, especially if joint destruction or abscess formation occurs. Addressing underlying health issues and preventive measures, such as vaccination against pneumococcus, can reduce the risk of future infections.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M00.19 a billable ICD-10 code?
Yes, M00.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M00.19?
Clinical documentation must specify the nature of Pneumococcal polyarthritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference